Locally Advanced or Metastatic Urothelial Carcinoma

Oncology·MeSH: Carcinoma, Transitional Cell

7 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
avelumab	GH Research PLC (GHRS)

Phase 2(6)

Drug	Company
Avelumab	NEKTAR THERAPEUTICS (NKTR)
m6223	GH Research PLC (GHRS)
M6223	NEKTAR THERAPEUTICS (NKTR)
nktr-255	GH Research PLC (GHRS)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	NEKTAR THERAPEUTICS (NKTR)

Compare drugs

avelumab vs m6223 avelumab vs nktr-255 avelumab vs sacituzumab govitecan

Frequently asked questions

How many drugs are in development for Locally Advanced or Metastatic Urothelial Carcinoma?

BioSniper tracks 7 drugs in development for Locally Advanced or Metastatic Urothelial Carcinoma across 2 companies.

How many clinical trials target Locally Advanced or Metastatic Urothelial Carcinoma?

There are 1 clinical trial targeting Locally Advanced or Metastatic Urothelial Carcinoma tracked by BioSniper.

Deep-dive into Locally Advanced or Metastatic Urothelial Carcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Locally Advanced or Metastatic Urothelial Carcinoma — Drugs in Development & Clinical Trials | BioSniper